In their efforts to tackle the COVID-19 crisis, decision makers are considering the development and use of smartphone applications for contact tracing. Even though these applications differ in technology and methods, there is an increasing concern about their implications for privacy and human rights. Here we propose a framework to evaluate their suitability in terms of impact on the users, employed technology and governance methods.
Artificial intelligence and machine learning technologies have the potential to transform health care by deriving new and important insights from the vast amount of data generated during the delivery of health care every day. Medical device manufacturers are using these technologies to innovate their products to better assist health care providers and improve patient care. The FDA is considering a total product lifecycle-based regulatory framework for these technologies.
This report explores the current state of affairs in Encrypted Traffic Analysis and in particular discusses research and methods in 6 key use cases; viz. application identification, network analytics, user information identification, detection of encrypted malware, file/device/website/location fingerprinting and DNS tunnelling detection.
FDA need to widen their scope from evaluating medical AI/ML-based products to assessing systems. This shift in perspective—from a product view to a system view—is central to maximizing the safety and efficacy of AI/ML in health care, but it also poses significant challenges for agencies like the FDA who are used to regulating products, not systems. We offer several suggestions for regulators to make this challenging but important transition
The starting point to develop the operational definition is the definition of AI adopted by the High Level Expert Group on artificial intelligence. To derive this operational definition we have followed a mixed methodology. On one hand, we apply natural language processing methods to a large set of AI literature. On the other hand, we carry out a qualitative analysis on 55 key documents including artificial intelligence definitions from three complementary perspectives: policy, research and industry.
Phyton’s most notable points are:
-Is a great library ecosystem (Scikit-learn, Pandas, Matplotlib, NLTK, Scikit-image, PyBrain, Caffe, StatsModels, TensorFlow, Keras, etc).
-Growing popularity.
-Has a low entry barrier, has flexibility, is a platform independence, has readability, good visualization options, good community support and growing popularity.
The purpose of this White Paper is to set out policy options on how to achieve these objectives. It does not address the development and use of AI for military purposes.The Commission invites Member States, other European institutions, and all stakeholders, including industry, social partners, civil society organisations, researchers, the public in general and any interested party, to react to the options and to contribute to the Commission’s future decision-making in this domain.
